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Using ameba coculture, we grew a Naegleria endo-
symbiont. Phenotypic, genetic, and phylogenetic analyses 
supported its affi liation as Protochlamydia naegleriophila 
sp. nov. We then developed a specifi c diagnostic PCR for 
Protochlamydia spp. When applied to bronchoalveolar la-
vages, results of this PCR were positive for 1 patient with 
pneumonia. Further studies are needed to assess the role 
of Protochlamydia spp. in pneumonia.  
Recently, a Naegleria endosymbiont (KNic) was ob-served but remained uncultivable, precluding precise 
identifi cation (1). We grew a large amount of strain KNic 
by using Acanthamoeba castellanii, which enabled phe-
notypic, genetic and phylogenetic analyses that supported 
its affi liation as Protochlamydia naegleriophila. This new 
ameba-resistant intracellular bacteria might represent a 
new etiologic agent of pneumonia because it is likely also 
resistant to human alveolar macrophages (2,3). Because 
other Parachlamydiaceae were associated with lung infec-
tion (4–6), we assessed the role of Pr. naegleriophila in 
pneumonia by developing a diagnostic PCR and applying 
it to bronchoalveolar lavages.
The Study
KNic growth in A. castellanii was assessed by immu-
nofl uorescence (7) with in-house mouse anti-KNic and Al-
exa488-coupled anti-immunoglobulin antibodies (Invitro-
gen, Eugene, OR, USA). Confocal microscopy (LSM510; 
Zeiss, Feldbach, Switzerland) confi rmed the intracellular 
location of KNic and demonstrated its rapid growth within 
A. castellanii. To precisely assess the growth rate, we per-
formed PCR on A. castellanii/KNic coculture by using PrF/
PrR primers and PrS probe. After 60 hours, we observed 
an increased number of bacteria per microliter of 4 loga-
rithms (online Appendix Figure, available from www.cdc.
gov/EID/content/14/1/167-appG.htm).
A. castellanii/KNic and N. lovaniensis/KNic cocul-
tures were processed for electron microscopy as described 
(7). Ameba fi lled with bacteria exhibiting 3 developmental 
stages already described in other Parachlamydiaceae (8) 
were observed (Figure 1).
To measure the serologic differentiation index (SDI) 
between strain KNic and other Chlamydia-like organisms, 
we immunized Balb/c mice to produce anti-KNic antibod-
ies. Purifi ed Pr. amoebophila (ATCC PRA-7), Simkania 
negevensis (ATCC VR-1471), Parachlamydia acanth-
amoebae strain Seine, Waddlia chondrophila (ATCC 1470), 
Neochlamydia hartmannellae (ATCC 50802), Criblamydia 
sequanensis (CRIB 18), and Rhabdochlamydia crassifi cans 
(CRIB 01) antigens were tested by micro-immunofl uores-
cence against mouse anti-KNic antibodies, whereas KNic 
antigen was tested with serum against all these different 
Chlamydia-like organisms (9). SDIs were calculated as 
described (9,10). Serum from mice immunized with KNic 
showed strong reactivity against autologous antigen (titers 
of 4,096). Signifi cant cross-reactivity between KNic and 
Pr. amoebophila (SDI = 7) and P. acanthamoebae (SDI 
= 10) was observed. Mouse anti-KNic serum did not react 
with other Chlamydia-like organisms (Table 1). Because 
cross-reactivity between members of the order Chlamydi-
ales was proportional to the relatedness between each spe-
cies (9), the strong cross-reactivity between KNic and Pr. 
amoebophila supports the affi liation of KNic in the genus 
Protochlamydia.
Taxonomic position of KNic was further defi ned by 
sequencing 16Sr RNA (rrs, DQ635609) and ADP/ATP 
translocase (nnt, EU056171) encoding genes. The rrs 
was amplifi ed/sequenced using 16SIGF/RP2Chlam prim-
ers (11). The nnt was amplifi ed/sequenced using nntF2p 
(5′-TGT(AT)GAT(CG)CATGGCAA(AG)TTTC-3′) and 
nntR1p (5′-GATTT(AG)CTCAT(AG)AT(AG)TTTTG-3′) 
primers. Genetic and phylogenetic analyses were conducted 
by using MEGA software (12). The 1,467-bp rrs sequence 
showed 97.6% similarity with Pr. amoebophila, 91.8%–
93.2% with other Parachlamydiaceae, and 85.7%–88.6% 
with other Chlamydiales. Based on the Everett genetic 
criteria (13), KNic corresponds to a new species within 
the Protochlamydia genus because its sequence similarity 
with Pr. amoebophila is >95% (same genus) and <98.5% 
(different species). Phylogenetic analyses of rrs gene se-
quences showed that KNic clustered with Pr. amoebophila, 
with bootstraps of 98% and 95% in neighbor-joining and 
minimum-evolution trees, respectively. The 569-bp nnt se-
quence exhibited 91.1% similarity with Pr. amoebophila, 
65.5%–72.6% with other Parachlamydiaceae, and 55.4%–
72.6% with other Chlamydiales. Phylogenetic analyses of 
nnt sequences showed that KNic clustered with Pr. amoe-
bophila. On the basis of these analyses, we propose to name 
strain KNic “Protochlamydia naegleriophila.”
We then developed a specifi c diagnostic PCR for 
Protochlamydia spp. Primers PrF (5′-CGGTAATACG
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GAGGGTGCAAG-3′) and PrR (5′-TGTTCCGAGGTT
GAGCCTC-3′) as well as probe PrS (5′-TCTGACTGAC
ACCCCCGCCTACG-3′) were selected. The 5′-Yakima-
Yellow probe (Eurogentec, Seraing, Belgium) contained 
locked nucleic acids (underlined in sequence above). The 
reactions were performed with 0.2 μM each primer, 0.1 
μM probe, and iTaqSupermix (Bio-Rad, Rheinach, Swit-
zerland). Cycling conditions were as described (14), and 
PCR products were detected with ABIPrism7000 (Applied 
Biosystems, Rotkreuz, Switzerland). Each sample was am-
plifi ed in duplicate. Inhibition, negative PCR mixture, and 
extraction controls were systematically tested. 
To allow quantifi cation, a plasmid containing the tar-
get gene was constructed by cloning PCR products into 
pCR2.1-TOPO vector (Invitrogen, Basel, Switzerland). 
Recombinant plasmid DNA quantifi ed using Nanodrop 
ND-1000 (Witech, Littau, Switzerland) was 10-fold diluted 
and used as positive controls.
The analytical sensitivity was 10 copy/μL (Figure 2, 
panel A). Intra-run variability was good (Figure 2B) with 
a Bland-Altman bias of 0.99 and a limit of agreement of 
2.87 (Figure 2, panel A). Inter-run variability was low at 
high concentration, 1.12, 1.71, 0.82, 1.77 cycles for 105, 
104, 103, 102 copies/μL, respectively. Inter-run variability 
was higher at low concentration, 4.22 cycles for 101 cop-
ies/μL (Figure 2, panel A). Analytical specifi city was tested 
with bacterial and eukaryotic DNA (Table 2). The PCR 
slightly amplifi ed DNA from R. crassifi cans, another Chla-
mydia-like organism. No cross-amplifi cation was observed 
with any other bacteria or with human cells. The absence 
of cross-amplifi cation of P. acanthamoebae is important 
because this Chlamydia-related bacteria is considered an 
emerging agent of pneumonia (4–6).
We tested 134 bronchoalveolar lavage samples from 
patients with (n = 65) and without (n = 69) pneumonia and 
extracted DNA by using a Bio-Rad Tissue Kit.  One sample 
was positive, with 543 and 480 copies/μL. This positive 
result was confi rmed using the 16sigF/16sigR PCR (13), 
which targets another DNA segment. This sequence ex-
hibited 99.6% (284/285) similarity with Pr. naegleriophila 
Figure 1. Transmission electron microscopy of Protochlamydia naegleriophila. A) Naegleria lovaniensis trophozoite after transfer of 
endocytobionts; strain KNic (p) from the original host strain showing 15 coccoid bacteria distributed randomly within the cytoplasm of 
the host ameba. N, nucleus; en, endosome (karyosome) within the nucleus; v, empty food vacuoles. Magnifi cation ×10,500; bar = 1 μm. 
B) N. lovaniensis trophozoite jammed with numerous endoparasitic stages of Pr. naegleriophila. Magnifi cation ×16,800; bar = 1 μm. C) 
Enlarged detail of N. lovaniensis trophozoite with intracytoplasmic stages of Pr. naegleriophila. Some stages show binary fi ssion indicated 
by the fi ssion furrow (arrows). The endoparasites have a wrinkled gram-negative outer membrane rendering a spiny appearance to the 
endoparasites. Signs of damage are obvious within the cytoplasm of the host ameba. mi, mitochondria. Magnifi cation ×43,500; bar = 0.5 
μm. D) Pr. naegleriophila within vacuoles of Acanthamoebae castellanii ameba 2 days postinfection. Elementary bodies (eb) and reticulate 
bodies (rb) are visible. Elementary bodies harbor a smooth membrane compared with the reticulate bodies, which have a spiny shape. 
Magnifi cation ×10,000; bar = 2 μm. E) Enlarged detail of A. castellanii trophozoite with intracytoplasmic stages of Pr. naegleriophila 3 days 
postinfection. Binary fi ssion is observed (di). Magnifi cation ×20,000; bar = 1 μm. F) Crescent body (arrow) within A. castellanii observed 3 
days postinfection. Magnifi cation ×20,000; bar = 1 μm.
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strain KNic and 95.1% (269/283) with Pr. amoebophila. 
The presence of Protochlamydia antigen in the sample was 
confi rmed by immunofl uorescence performed using rabbit 
anti-KNic antibody directly on the bronchoalveolar lavage 
sample and by ameba coculture (online Appendix Figure).
The positive sample was taken from an immunocom-
promised patient who had cough, dyspnea, and a lung in-
fi ltrate. Bronchoscopy examination of the lower respiratory 
tract showed mucosal infl ammation localized at the middle 
lung lobe. Cytology and Gram stain of the bronchoalveolar 
lavage showed many leucocytes with macrophages (65%) 
and neutrophils (23%). Although no antimicrobial treatment 
was administered prior to bronchoscopy, no other etiologic 
agent was identifi ed despite extensive microbiologic inves-
tigations of bronchial aspirate and bronchoalveolar lavage. 
Results of Gram stain, auramine stain (for Mycobacterium 
spp.), and silver stain (for Pneumocystis carinii) tests were 
negative. Only physiologic oropharyngeal fl ora could be 
grown on sheep-blood and chocolate-bacitracin agars. 
Cell culture, as well as culture for fungi and mycobacteria, 
remained sterile. Moreover, results of PCRs specifi c for 
the detection of Legionella pneumophila, Chlamydophila 
pneumoniae, and Mycoplasma pneumoniae (15) were all 
negative. The patient recovered and remained free of symp-
toms of acute lung infection during the next 20 months.
Table 1. Antibody titers and serologic differentiation index (SDI) obtained from reciprocal cross-reactions of mouse antiserum with 





















4,096 (0) 256 (7) <4 (14) 512 (10) 4 (20) 16 (14) <4 (20) <4 (13)
Pr.
amoebophila
32 (7) 256 (0) <32 (5) 1,024
(3)
64 (10) 32 (0) 128 (9) 64  (3)
S. negevensis 32 (14) 128 (5) 512 (0) 64 (12) 128 (12) <32 (12) 512 (8) 256 (3)
P. strain 
Seine
128 (10) 512 (3) 32 (12) 16,384
(0)
64 (19) 64 (12) <32 (19) <32 (12)
W. 
chondrophila
32 (20) 128 (10) 32 (12) <32 (19) 32,768 (0) <32 (18) 512 (13) 128 (10)
N.
hartmannellae
32 (14) 128 (0) <32 (12) 128 (12) <32 (18) 2,048 (0) <32 (18) <32 (11)
C.
sequanensis
32 (20) 128 (9) 128 (8) 64 (19) 256 (13) <32 (18) 32,768 (0) 128 (8)
R.
crassificans
32 (13) 128 (3) 64 (3) 64 (12) 64 (10) <32 (11) 256 (8) 256 (0)
*Pr., Protochlamydia; P.a., Parachlamydia acanthamoebae; R., Rhabdochlamydia. Titers highlighted in gray, previously published in (9), are provided 
here because these data were used to calculate SDI between Pr. naegleriophila strain KNIC and the other Chlamydia-related bacteria.  
Figure 2. A) Intra and inter-run reproducibility of the real-time PCR assessed on duplicate of plasmidic positive controls performed at 
10-fold dilutions from 105 to 101 plasmid/μL during 6 successive runs. Standard deviations show the intra-run reproducibility of the real-
time PCR. B) Plots of the cycle threshold (Ct) of fi rst and second duplicates, showing intra-run and inter-run variability of the real-time 
PCR between duplicates of positive control. 95% confi dence interval is shown by the dashed lines. C) Bland-Altman graph showing the 
difference of Ct of both duplicates according to the mean of the Ct of duplicates. The dashed line shows the 95% confi dence interval (i.e., 
limit of agreement).
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Conclusions
Isolating new species from environmental and clini-
cal samples is important to better defi ne their epidemiol-
ogy and potential pathogenicity. We defi ned the taxonomic 
position of a novel Naegleria endosymbiont and proposed 
its affi liation within the Protochlamydia genus as Pr. nae-
gleriophila sp. nov. Moreover, we developed a new PCR 
targeting Protochlamydia spp., applied it to clinical sam-
ples, and identifi ed a possible role of Pr. naegleriophila as 
an agent of pneumonia.
Protochlamydia naegleriophila (nae.gle.rio′.phi.la 
Gr. fem.n. Naegleria, name of host cell, Gr. adj. philos, 
-a friendly to, referring to intracellular growth of Proto-
chlamydia naegleriophila strain KNic within Naegleria 
amebae). The 16Sr RNA sequence (DQ635609) of KNic 
is 97.6% similar to that of P. amoebophila, making this or-
ganism a member of the genus Protochlamydia. KNic does 
not grow on axenic media (1) but grows by 4 logarithms in 
60 h within A. castellanii. KNic exhibits a Chlamydia-like 
developmental cycle, with reticulate, elementary, and cres-
cent bodies. The reticulate body is about 900 nm and has a 
spiny appearance similar to that of P. amoebophila (Figure 
2, panel B). To be classifi ed within the Pr. naegleriophila 
species, a new strain should show a 16Sr RNA similarity 
>98.5% (13) and similar phenotypic traits. 
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